Young BioPharma’s Pipeline
TRPV1 agonists as non-opioid pain therapy
- YB-16 — Proven efficacy and safety
- Projected clinical entry — 2025
Src activation blockers as anticancer agent
- YB — Effective in animal cancer model
- Projected clinical entry — 2026
Novel ion channel inhibitors as non-opioid pain therapy
- PF — Fungal natural product with oral drug-like structure
- Effective in animal model of pain
- Projected clinical entry — 2027
©Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.